尊龙凯时
About us
尊龙凯时:Our Values
尊龙凯时:Development Milestone
Products
尊龙凯时:Product List for API
尊龙凯时:Recommended API
尊龙凯时:Product list for Chemicals and Intermediates
Product list for Chemicals and Intermediates
News
尊龙凯时:Contract Manufacturing
尊龙凯时:API and Pharmaceutical Intermediates
尊龙凯时:OTC and Generics
Investor Relation
尊龙凯时:PERIODIC REPORT
尊龙凯时:INTERIM REPORT
尊龙凯时:INVESTORS SERVICE
尊龙凯时:Contact Us
About us
News
尊龙凯时:Investor Relation
Products
尊龙凯时:Contract Manufacturing
尊龙凯时:Contact Us
Investor Relation
Investor Relation
尊龙凯时:PERIODIC REPORT
尊龙凯时:INTERIM REPORT
尊龙凯时:INVESTORS SERVICE
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023
2023-07-03
Articles of Association
2023-06-26
Overseas Regulatory Announcement-Announcement on Alogliptin Benzoate Obtaining Notification of Approval of Marketing Application for Chemical Raw Material Drugs
2023-06-20
Overseas regulatory announcement-Announcement on Rabeprazole Sodium Enteric-coat
2023-06-13
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023
2023-06-01
Proposed Amendments To The Articles of Association And Notice of The Annual Gene
2023-05-23
Notice of The Annual General Meeting
2023-05-23
Proxy Form for 2022 Annual General Meeting
2023-05-23
Reply Slip for 2022 Annual General Meeting
2023-05-23
Overseas Regulatory Announcement-Announcement on Obtaining the Drug Registration
2023-05-18
<
...
9
10
11
12
13
14
15
...
>